Detergent-soluble DNA is the fraction (2-4%) of DNA that is released into the supernate upon mild detergent lysis. It is nonmitochondrial in origin. It labels efficiently with deoxy[3H]ribonucleosides and the labeling is prevented by inhibitors of polymerase a and ribonucleotide reductase. In previous publications we have characterized detergent-soluble DNA from splenocytes of immunologically activated mice. In this publication we show that incorporation of [3H]thymidine into detergent-soluble DNA is prevented by pretreatment with novobiocin, 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA), and teniposide (VM26), three inhibitors of type II topoisomerases. Camptothecin, an inhibitor of type I topoisomerases, also reduces incorporation of [3H]thymidine but only to 50% of control levels. In addition to affecting incorporation of [3lHlthymidine, preincubation with the topoisomerase II inhibitors m-AMSA and VM26 alters the amount of DNA recovered in the detergent-soluble fraction. At low concentrations of m-AMSA the amount of detergent-soluble DNA increases somewhat, whereas at higher drug concentrations a marked decrease is observed. Treatment with VM26 results in diminished amounts of DNA being released into the detergent-soluble fraction as well. However, maximal inhibition of detergent-soluble DNA release by VM26 requires the presence of camptothecin. Therefore, we suggest that topoisomerases play an important role in making a small part of lymphocyte chromatin detergent labile. Furthermore, these results are consistent with recent studies demonstrating a role for topoisomerases in yeast replication. Thus, the newly synthesized portion of detergent-soluble DNA may arise as DNA replication intermediates not yet stabilized into mature chromatin.
inhibitors of polymerase a and ribonucleotide reductase. In previous publications we have characterized detergent-soluble DNA from splenocytes of immunologically activated mice. In this publication we show that incorporation of [3H]thymidine into detergent-soluble DNA is prevented by pretreatment with novobiocin, 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA), and teniposide (VM26), three inhibitors of type II topoisomerases. Camptothecin, an inhibitor of type I topoisomerases, also reduces incorporation of [3H] thymidine but only to 50% of control levels. In addition to affecting incorporation of [3lHlthymidine, preincubation with the topoisomerase II inhibitors m-AMSA and VM26 alters the amount of DNA recovered in the detergent-soluble fraction. At low concentrations of m-AMSA the amount of detergent-soluble DNA increases somewhat, whereas at higher drug concentrations a marked decrease is observed. Treatment with VM26 results in diminished amounts of DNA being released into the detergent-soluble fraction as well. However, maximal inhibition of detergent-soluble DNA release by VM26 requires the presence of camptothecin. Therefore, we suggest that topoisomerases play an important role in making a small part of lymphocyte chromatin detergent labile. Furthermore, these results are consistent with recent studies demonstrating a role for topoisomerases in yeast replication. Thus, the newly synthesized portion of detergent-soluble DNA may arise as DNA replication intermediates not yet stabilized into mature chromatin.
Topoisomerases are a group of enzymes that interconvert various topological isomers of DNA without altering the nucleotide sequence (1) (2) (3) . Type II topoisomerases result in 2n changes in linking number through transient doublestranded breaks and covalent insertion of the enzyme at the 5' end of DNA. The energy for rejoining the broken strand(s) comes from an enzyme-associated ATPase activity (4) . Type I topoisomerases produce unit changes in linking number by means of single-stranded breaks and covalent insertion of the enzyme at the 3' end of DNA (5) . Because of the topological constraints of DNA replication, some sort of topoisomerase involvement is likely (6) . It is now accepted that resolution of intertwined pairs of newly replicated DNA molecules involves type II DNA topoisomerases (7, 8) and that topoisomerases are required for replication in yeast (9 (11, 12) . Novobiocin was purchased from Sigma. The anticancer drug 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) was the gift of Michael Mattern or was obtained through the courtesy of Ven Narayanan (Department of Health and Human Services). VM26 was the gift of Leroy Liu or was obtained through the courtesy of Dale Stringfellow (Bristol Myers Co.). Camptothecin was obtained from Ven Narayanan.
[3H]Thymidine, obtained either from Dupont-NEN Products (Boston, MA) or from Amersham, was purified before use as described (10) .
DNA Isolation and Analysis. DNA, isolated from the detergent-soluble fraction and purified as described earlier (11, 12) , was resolved by means of electrophoresis using native 1.2% agarose gels. Standards obtained from New England Biolabs were A DNA digested with HindIII or 4X174 replicative form (RF) DNA digested with Hae III. The amount of DNA in each lane was determined from the photograph of the ethidium bromide staining pattern by scanning densitometry using the Shimadzu TLC Scanner Abbreviation: m-AMSA, 4'-(9-acridinylamino)methanesulfon-m-anisidide. *To whom reprint requests should be addressed.
5871
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
(Columbia, MD). The area under the curve for the unknown was compared with the area under the curve for known amounts of 4X174 RF DNA digested with Hae III run on the same gel. To determine the location of the incorporated radiolabel, the gel was cut into 2-mm slices, melted in 1.0 ml of deionized, distilled H20, dissolved in 5.0 ml of Scintiverse (Fisher, Medford, MA), and assayed for radioactivity scintillation spectrometry. Alternatively, the gel was processed for fluorography by using New EN HANCE (Dupont-NEN Products, Boston, MA) or Amplify (Amersham). The incorporation of [3H]thymidine was determined by scintillation spectrometry after chromatin in the detergent-insoluble fraction was sheared repeatedly in 8 detergent-insoluble fraction to a lesser extent than into the detergent-soluble fraction. For example, at 50 ,uM novobiocin, incorporation into DNA in the detergent-insoluble fraction was 95% of control, whereas incorporation into DNA in the detergent-soluble fraction was 32% of control. At 200 AM novobiocin, incorporation into DNA in the detergent-insoluble fraction was 37% of control, whereas incorporation into DNA in the detergent-soluble fraction was 4% of the control value.
m-AMSA Inhibits the Appearance of DNA in the DetergentSoluble Fraction in a Biphasic Fashion. Novobiocin inhibits not only topoisomerase II but also other enzymes with ATPase-associated activity such as DNA polymerase a (16) and DNA ligase (17) . To further implicate topoisomerase II, we turned to other inhibitors with different modes of action. The drug m-AMSA inhibits topoisomerase II by forming a ternary complex with the enzyme and DNA so that the enzyme dissociates poorly from DNA (18, 19) . When splenocytes were preincubated for 30 or 60 min with m-AMSA at concentrations of 1 ,M or greater, incorporation of [3H]thymidine into DNA recovered in the detergent-soluble fraction was inhibited (Figs. 2 and 3) . At each concentration, [3H]thymidine incorporation into DNA from the detergentsoluble fraction was inhibited to a greater extent than incorporation into the detergent-insoluble fraction. In contrast to the incorporation data, the amount ofDNA recovered in the detergent-soluble fraction of splenocytes was increased by 10-30% at low concentrations of m-AMSA (1) (2) (3) (4) (5) ,AM), whereas treatment with m-AMSA at 50 ,M and 100 AM resulted in diminished amounts of DNA in the detergentsoluble fraction (see Fig. 2 DNA diminished, the smaller size classes were lost preferentially. In Fig. 2 , for example, DNA of 1400 base pairs and smaller decreased from 55% of the total detergent-soluble DNA from control cells to 14% of the total detergent-soluble DNA isolated from splenocytes treated with 100 ,uM m-AMSA. At the same time there was a tendency to accumulate DNA of the largest size classes. The drug m-AMSA has been shown to induce strand breaks in mouse L1210 cells in a reversible manner (18 (Fig. 3) . Although [3H]thymidine incorporation was diminished by 85% or more by 50-100 AM VM26, the amount of DNA accessible to detergent solubilization decreased only by 35% (Fig. 4) . The size distribution of DNA remaining in the detergent-soluble fraction did not change.
Because type I and type II topoisomerases can substitute in some reactions for each other in yeast (7-9), we examined the effects of camptothecin, an inhibitor of type I topoisomerase (19) , alone and together with VM26. The effects of camptothecin (lactone form) on incorporation of [3H]thymidine into DNA from the detergent-soluble and detergent-insoluble fractions as a function of concentration are shown in Fig. 3 . Below 10 AuM, camptothecin was as effective on a molar basis as VM26 in inhibiting [3H]thymidine incorporation. However, inhibition was never more than 55%. Furthermore, treatment with 125 ,uM camptothecin resulted in only 25% inhibition of release of DNA into the detergent-soluble fraction.
Simultaneous treatment with VM26 and camptothecin, however, gave striking results (Fig. 4) . Pretreatment with 100 ,uM VM26 and 125 ,uM camptothecin together resulted in 86% inhibition of [3H]thymidine incorporation into detergentsoluble DNA and 71% reduction in the amount of DNA accessible to detergent solubilization. The same treatment resulted in 73% inhibition of [3H]thymidine incorporation into DNA in the detergent-insoluble fraction. Since the three topoisomerase II inhibitors act by distinct mechanisms (20, 21) , secondary effects on other enzymes are unlikely. Therefore, it appears that topoisomerases are involved in rendering certain DNA available to release into the detergent-soluble fraction.
Detergent-soluble DNA is that fraction of DNA released from chromatin by detergent treatment of dividing cells (11, 12) . Nonmitochondrial in origin (11) , it can be isolated from a wide variety of cell types, including splenocytes from immunologically active mice (11, 12) , erythroblasts from phenylhydrazine-treated anemic mice, various mouse and human lymphocyte lines (T and B), murine erythroleukemia cells, Chinese hamster ovary cells, HeLa cells, and, finally, Xenopus laevis and Drosophila melanogaster embryos (unpublished data). It is metabolically active since it is labeled more efficiently with [3H]thymidine than is bulk chromatin, which remains in the detergent-insoluble fraction (11, 12, 23) . Detergent-soluble DNA has been observed in the past by a number ofinvestigators (24) (25) (26) . Its origin has been described as cytoplasmic, membranous, or artifactual, the result of cell death and/or a calcium, magnesium-activated endonuclease activity unrelated to cell division. Although cell death may result in nuclear fragmentation, the results presented here suggest most detergent solubility arises from the ongoing interaction of topoisomerases with chromatin. The observation that camptothecin augments the effect of VM26 suggests that the remaining metabolically. inactive detergent-soluble DNA may be generated by type I topoisomerase activity or a combination of the two topoisomerase types. We add that lysis under conditions that would be expected to completely inhibit known DNA nucleases-e.g., lysis with sodium dodecyl sulfate or lysis in the presence of diethylcarbonatealso generates DNA in the detergent-soluble fraction with the same size distribution as that obtained under conditions described here (E. Palome, J.C.T., and P.R.S., unpublished data). Hence, detergent-soluble DNA is unlikely to be generated by nonspecific, "promiscuous" nucleases.
About 2-4% of total DNA from splenocytes of mice that have been immunologically activated is recovered in the detergent-soluble fraction (11) . Therefore, we suggest that this DNA is transiently located between two nearby topoisomerase molecules. The DNA is released into the soluble fraction when the enzyme-DNA interaction is interrupted by detergent treatment. We cannot exclude the possibility that additional longer fragments are created that are detergent insoluble simply because of their size. Although detergentsoluble DNA represents <5% of the total cellular DNA and its specific activity is increased over that of DNA recovered from the detergent-insoluble fraction (11, 12) (9) . When both topoisomerase classes are completely inactivated, cell growth and division in yeast finally stop.
